cesarean scar.
Conditions
Interventions
Intervention 1: Intervention group: injection of methotrexate in the amount of 1.5 square centimeters from an ampoule of 50 mg per 2 square centimeters from Daro Derman Pars Company into the sac or if
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Definitive diagnosis of incisional pregnancy Stable hemodynamic status Absence of severe vaginal bleeding Consent to participate in the study Pregnancy less than 10 weeks
Exclusion criteria
Exclusion criteria: History of drug sensitivity History of blood disorders Having liver disorders Having pulmonary disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of the study is the successful treatment of patients, which is the reduction of serum b-hCG levels until it become negative. Timepoint: Every week. Method of measurement: Radioimmunoassay.;The primary outcome of the study is the successful treatment of patients, by confirming the empty uterus on the ultrasound exam. Timepoint: Every mounth. Method of measurement: Transvaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazli Navali
Tabriz University of Medical Sciences
Outcome results
None listed